Cutaneous Adverse Events in Patients With Metastatic Melanoma Consecutively Treated With Anti-CTLA4 and Anti–PD-1 Combination Immunotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti-CTLA4 and anti-PD1 combination immunotherapy: Incidence, management, and clinical benefit
Cancer 2021 Nov 01;[EPub Ahead of Print], AB Patel, S Farooq, M Welborn, RN Amaria, SY Chon, A Diab, IC Glitza Oliva, AO Huen, SQ Li, KC Nelson, O Pacha, SP Patel, RP Rapini, HA Tawbi, MK Wong, J McQuade, MA Davies, LE HayduFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.